Skip to main content

Dr. Tomasz Rygiel Delivers Pioneering Lecture on Macrophage-Based Immunotherapy at the 5th Macrophage-directed Therapies Summit

We’re here! 🌟 Dr. Tomasz Rygiel, Chief Scientific Officer and Co-Founder of Cellis, is present at the 5th Macrophage-Directed Therapies Summit! His presentation on “Breakthrough Macrophage-Based Immunotherapy for Treatment of Solid Tumors” was an incredible highlight. A massive thank you to the organizers for the incredible platform, and a special shout-out to the audience—your reception of the lecture was overwhelmingly positive! 🙌 #MacrophageTherapies #Immunotherapy #CellisInnovates